Bianca M.
- Country
- The Netherlands
- Department
- Medical Oncology
Research Overview
- Phase I Study of Perioperative Intraperitoneal Irinotecan and Systemic FLOT Combination Therapy for Curative Gastric and Gastroesophageal Junction Cancer
- Phase III Randomized Trial of AZD0901 with Capecitabine ± Rilvegostomig in First‑Line Claudin‑18.2‑Positive HER2‑Negative Advanced Gastric, GEJ or Esophageal Adenocarcinoma
- Phase II Dose Escalation Study of Oral Capecitabine Substitution for 5‑FU in Perioperative FLOT Regimen for Resectable Gastric and Esophageal Adenocarcinoma
Data & Insights
Has run more than one trial at 94 of 244 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in the treatment of gastric cancer and gastroesophageal junction adenocarcinoma, with particular focus on resectable disease management and innovative therapeutic approaches.
- Resectable gastric cancer
- Neoadjuvant-adjuvant therapy
- Stage II and higher gastric malignancies
Investigates combined treatment modalities for gastrointestinal cancers.
Colorectal Cancer Treatment
Focuses on advanced therapeutic strategies for colorectal liver metastases, incorporating both regional and systemic treatment approaches.
- Hepatic arterial infusion therapy
- Liver-limited colorectal cancer
- Combined chemotherapy protocols
Explores innovative delivery methods for chemotherapy in colorectal cancer treatment.
Advanced Gastric Cancer
Specializes in treating HER2-positive gastric cancer and unresectable gastroesophageal malignancies, with emphasis on targeted therapeutic approaches.
- Metastatic HER2-positive disease
- Targeted therapy combinations
- First-line treatment strategies
Investigates novel therapeutic combinations for advanced gastric cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.